FRANKFURT--The following is a summary of analysts' forecasts for Merck KGaA (MRK.XE) first-quarter results (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released May 18.

=== 
.                               Forecast Change         Reported 
1st Quarter                         1Q17   in %  Number     1Q16 
Total Sales                        3,842    +5%     9      3,665 
Sales Rebif                          419    -1%     7        422 
Sales Erbitux                        213    +3%     7        207 
EBITDA - Adjusted                  1,191   +10%     4      1,084 
Net Income Attributable - Adjusted   740   +11%     4        669 
Net Income Attributable              540    -9%     1        591 
Earnings Per Share - Adjusted       1.71   +11%     6       1.54 
Dividend Per Share                  1.29    +8%    18       1.20 
 
Target Price                      111.00           21 
=== 

Year-earlier figures are as reported by the company. Data provided by Factset.

DJG/voi 

(END) Dow Jones Newswires

May 16, 2017 03:41 ET (07:41 GMT)